SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Treatment of gangrenous digit-threatening paraneoplastic acrocyanosis with vasodilator therapy.

Biddle, K; Nathan, J; Sandhu, V (2023) Treatment of gangrenous digit-threatening paraneoplastic acrocyanosis with vasodilator therapy. BMJ Case Rep, 16 (2). e251417. ISSN 1757-790X https://doi.org/10.1136/bcr-2022-251417
SGUL Authors: Biddle, Kathryn Sandhu, Virinderjit

[img] Microsoft Word (.docx) Accepted Version
Available under License ["licenses_description_publisher" not defined].

Download (40kB)
[img] Microsoft PowerPoint (Figure 5) Accepted Version
Available under License ["licenses_description_publisher" not defined].

Download (921kB)

Abstract

A man in his 70s, with a recent diagnosis of transitional cell carcinoma of the bladder, reported a 2-month history of discolouration, pain and paraesthesia affecting his fingers. Clinical assessment noted peripheral acrocyanosis with areas of digital ulceration and gangrene. Following further work-up to evaluate potential causes, he was diagnosed with paraneoplastic acrocyanosis. He proceeded to undergo robotic cystoprostatectomy and received adjuvant chemotherapy for the management of his cancer. In parallel to the chemotherapy, vasodilatory therapy was administered as two courses of intravenous synthetic prostacyclin analogue iloprost along with sildenafil. This resulted in a significant improvement in digital pain and gangrene with healing of ulceration.

Item Type: Article
Additional Information: This article has been accepted for publication in BMJ Case Reports, 2023 following peer review, and the Version of Record can be accessed online at https://doi.org/10.1136/bcr-2022-251417 © BMJ Publishing Group Limited 2023.
Keywords: Oncology, Rheumatology, Male, Humans, Vasodilator Agents, Gangrene, Iloprost, Epoprostenol, Sildenafil Citrate, Humans, Gangrene, Epoprostenol, Iloprost, Vasodilator Agents, Male, Sildenafil Citrate, Oncology, Rheumatology, Epoprostenol, Gangrene, Humans, Iloprost, Male, Sildenafil Citrate, Vasodilator Agents, Oncology, Rheumatology, 1103 Clinical Sciences
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Academic Structure > Institute of Medical & Biomedical Education (IMBE)
Journal or Publication Title: BMJ Case Rep
ISSN: 1757-790X
Language: eng
Dates:
DateEvent
4 July 2023Published
21 February 2023Published Online
10 February 2023Accepted
Publisher License: Publisher's own licence
PubMed ID: 36810331
Web of Science ID: WOS:000938418700005
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/116763
Publisher's version: https://doi.org/10.1136/bcr-2022-251417

Actions (login required)

Edit Item Edit Item